ESC 365 - Frailty and outcomes in octogenarians with atrial fibrillation treated with edoxaban: ESCAPE study

ESC Professional Premium Access

Frailty and outcomes in octogenarians with atrial fibrillation treated with edoxaban: ESCAPE study

Session: Challenges in cardiovascular pharmacotherapy in patients who are older or with comorbidities

Topic: Anticoagulants

Speaker: Doctor G. Denas (Padova, IT)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Gentian Denas

University of Padua, Padova (Italy)

1 presentation

0 follower

7 more presentations in this session

The use of warfarin as part of antithrombotic strategy after transcutaneous aortic valve replacement is not associated with better medium-term outcomes

Speaker: Doctor J. Naser (Rochester, US)

Direct oral anticoagulants compared to vitamin K antagonists for the treatment of left ventricular thrombi

Speaker: Doctor H. Morgan (London, GB)

Oral anticoagulant therapy and decline of kidney function in elderly patients with non-valve atrial fibrillation: real world evidence data

Speaker: Doctor G. Severini (Catanzaro, IT)

Previous antithrombotic therapy does not have an impact on the in-hospital mortality of patients with upper gastrointestinal bleeding

Speaker: Doctor M. Hozman (Prague, CZ)

The association of angiotensin-converting enzyme inhibitors and angiotensin 2 receptor blockers with renal protection in patients with SARS-CoV-2

Speaker: Mr S. Tan (New York, US)

Access the full session

Challenges in cardiovascular pharmacotherapy in patients who are older or with comorbidities

Speakers: Doctor G. Denas, Doctor J. Naser, Doctor H. Morgan, Doctor G. Severini, Doctor M. Hozman...

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources